| News
BaseLaunch is now accepting applications
05.06.2020
BaseLaunch helps build therapeutic ventures to the point where they can raise a Series-A financing round or similar.
Are you developing novel therapeutics, or novel therapeutic platforms? We are looking for highly innovative pharma-biotech projects to support. One major thing we provide to help get companies there is funding – up to USD $ 500,000 per venture. Learn more at www.baselaunch.ch
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Nouscom secures 67.5 million euros in financing
Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More
Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023
On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More
Paradigm shift in pain management
Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More
BOOM Summit in Basel accelerates health technology
The BOOM Summit at Messe Basel in April 2024 will be a completely new kind of healthcare conference. The first...
Read More
Investors stump up 3.7 million Swiss francs in Onena Medicines
Basel Area Business & Innovation Innovation Invest Life Sciences / biotech Switzerland Innovation Park
Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More
CSL joins Basel Area biotech cluster
Basel Area Business & Innovation Innovation Invest Life Sciences / biotech Switzerland Innovation Park
The research and development department of the globally active Australian biotech company CSL has moved into a new office in...
Read More
